iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

The USFDA has warned Cipla about its manufacturing processes at its Pithampur factory

20 Nov 2023 , 12:29 PM

The US Food and Drug Administration (US FDA) has issued a warning letter to Cipla, a prominent player in the pharmaceutical industry, regarding the routine current Good Manufacturing Practices (cGMP) inspection that was carried out at its Pithampur manufacturing plant from February 6 to February 17, 2023.

This warning letter outlines infractions pertaining to procedures or controls used at the facility that do not follow the specified cGMP rules and offers instructions for making the required corrections.

The company notified the exchanges that it will reply to the Warning Letter within the allotted time frames and that it will collaborate closely with the US FDA to address the issues in a comprehensive and timely manner in order to ensure sustained compliance. ‘We uphold quality and compliance with utmost importance and remain committed to be compliant with cGMP quality standards,’ added the statement.

For feedback and suggestions, write to us at editorial@iifl.com

Cipla - Wikipedia

Related Tags

  • Cipla
  • USFDA
  • Warning
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.